Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3752120017 | Haloperidol (as haloperidol decanoate) 50 mg/mL oil for injection | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3752121018 | Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) | Has basis of strength substance (attribute) | Haloperidol (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) | Has concentration strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) | Has precise active ingredient | Haloperidol decanoate (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) | Has concentration strength denominator unit | mL | false | Inferred relationship | Some | 1 | |
| Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) | Has concentration strength numerator value | 50 | false | Inferred relationship | Some | 1 | |
| Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) | Is a | Haloperidol only product in parenteral dose form | false | Inferred relationship | Some | ||
| Product containing precisely haloperidol (as haloperidol decanoate) 50 milligram/1 milliliter prolonged-release oil for injection (clinical drug) | Has manufactured dose form | Prolonged-release oil for injection | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
ALTERNATIVE association reference set (foundation metadata concept)
FHIR